Clinical trials for Bladder cancer

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bladder cancer. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bladder cancer

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bladder cancer
Title Recruitment status Location
A Phase III randomised trial of PeriOperative chemotherapy versus sUrveillance in upper Tract urothelial cancer Recruiting United Kingdom
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer Recruiting United Kingdom
Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers. Recruiting United Kingdom
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer Recruiting United Kingdom
PHOTOdynamic versus white light-guided treatment of non-muscle invasive bladder cancer: randomised trial of clinical and cost-effectiveness Recruiting United Kingdom
Safety and Tolerability of GemRIS 225 mg in Subjects With Non-Muscle-Invasive Bladder Cancer Recruiting United Kingdom
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer Recruiting United Kingdom
NEOadjuvant chemotherapy study of Nintedanib with Gemcitabine and Cisplatin in locally advanced muscle invasive BLADder cancEr Recruiting United Kingdom
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Recruiting United Kingdom
A Phase III, Open-Label, Multicenter, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Versus Observation as Adjuvant Therapy in Patients With PD-L1-Selected, High-Risk Muscle-Invasive Bladder Cancer After Cystectomy Recruiting United Kingdom

Page last reviewed:

Next review due: